EP0016431B1 - Nose clip for the prophylactic or therapeutic treatment of cattle - Google Patents

Nose clip for the prophylactic or therapeutic treatment of cattle Download PDF

Info

Publication number
EP0016431B1
EP0016431B1 EP80101337A EP80101337A EP0016431B1 EP 0016431 B1 EP0016431 B1 EP 0016431B1 EP 80101337 A EP80101337 A EP 80101337A EP 80101337 A EP80101337 A EP 80101337A EP 0016431 B1 EP0016431 B1 EP 0016431B1
Authority
EP
European Patent Office
Prior art keywords
clip
nose
depot
bodies
depot bodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
EP80101337A
Other languages
German (de)
French (fr)
Other versions
EP0016431A1 (en
Inventor
Dietrich Dr. Hiller
Peter Dr. Klatt
Bernhard Reul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19792910629 external-priority patent/DE2910629A1/en
Priority claimed from DE19792926283 external-priority patent/DE2926283A1/en
Application filed by Hoechst AG filed Critical Hoechst AG
Priority to AT80101337T priority Critical patent/ATE5229T1/en
Publication of EP0016431A1 publication Critical patent/EP0016431A1/en
Application granted granted Critical
Publication of EP0016431B1 publication Critical patent/EP0016431B1/en
Expired legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61DVETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
    • A61D7/00Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals

Definitions

  • the invention relates to nasal clips for the application of active substances for prophylactic or therapeutic treatments of cattle.
  • DE-C3-2 125464 describes nasal clips with the aid of which it is possible to deliver medicinal substances to the nasal mucosa of animals over a longer period of time. They consist of a bracket, the ends of which have devices for receiving active substances in the form of depot bodies. According to a preferred embodiment, the ends of the clasp, which carry the active ingredient, run parallel.
  • the object of the invention is to overcome the disadvantages shown.
  • the invention therefore relates to a nose clip for the prophylactic or therapeutic treatment of cattle, consisting of a hanger, the ends of which have devices for receiving active substances in the form of depot bodies, and is characterized in that either the temple ends with the devices or the surfaces of the depot body inclined towards each other and rotated towards each other.
  • the depot body can be divided into an active substance-free, dimensionally stable applicator and an associated, active substance-containing, variable shape reservoir.
  • the devices or the surfaces of the depot bodies are inclined relative to one another and rotated relative to one another. These angular positions overcome the disadvantages observed when wearing the nose clips corresponding to the prior art with parallel ends and consequently also parallel surfaces of the depot bodies. A safe long-term treatment without additional effort is possible with the nose clip according to the invention.
  • cattle means the animal species cattle.
  • the invention particularly relates to a nose clip which consists of a resilient, U-shaped bracket, the ends of which are inclined and rotated relative to one another and have devices for receiving active substances in the form of depot bodies.
  • the bracket 1 of the nose clip must have a strength that enables the anatomically correct fit of the depot body during the entire wearing time. On the other hand, it has to be elastic enough to enable the insertion and removal of the nasal clip and to be able to adapt to a certain extent to the growth of, for example, a calf during the wearing period of the nasal clip.
  • the optimal strength and relaxation when the bracket was bent by 2.5 mm were determined by force-displacement measurements and comparison with the results of wearing tests on calves and adult cattle. It has been shown that a bracket with a force of 0.5 N to 4 N, which is only slightly less after the wearing test, is particularly suitable. The force was determined on a material testing machine with a feed rate of 10 mm / min on a path of 2.5 mm at a temperature of
  • metals or plastics such as. B. polyamide, polystyrene, preferably polypropylene and polyacetal (polyoxymethylene).
  • the thickness of the bracket varies within certain limits and depends on the material.
  • the temple ends have devices 2 for receiving active substances in the form of depot bodies.
  • the devices are inclined towards one another and form an inclination angle ⁇ (FIG. 1) which is greater than 0 °. It is preferably 5 ° to 30 °, in particular 10 ° to 23 °.
  • the devices are also rotated relative to one another and have a torsion angle ⁇ (FIG. 3) which is preferably 2 ° to 45 ° and in particular 8 ° to 28 °. It arises from torsion of the temple ends designed as devices themselves or from torsion of the connecting parts.
  • torsion angle
  • the devices with the angles x and ß ensure the optimal adaptation of the nasal clip to the anatomical conditions of the nasal vestibule.
  • the torsion angle ß at the temple end prevents errors when assembling the nose clip and when attaching it to the application site.
  • the angles IX and ⁇ are formed by the depot bodies, i. that is, the angles are formed on the basis of special shapes of the depot bodies.
  • the nose clip according to the invention is used for the application of active substances, the application taking place over a long period of time (e.g. several weeks).
  • the active substance is therefore in the form of a depot body, the active substance as such being a depot body or forming the depot body with a carrier which delays the release of the active substance.
  • the depot body can also consist of an active substance molding with a surrounding shell.
  • the depot bodies can be fixed directly on the devices 2.
  • a connection part 3, 4, 16 (FIGS. 4 to 12), which establishes the connection between the devices at the temple end and the depot body, is preferably located on the devices 2.
  • the side of the connecting part facing the devices preferably has the shape 3, 4, 16 shown in FIGS. 4 to 12.
  • the diameter, thickness and shape of the plate-shaped parts 3 and 4 of the connecting part need not be identical.
  • the depot bodies can be produced as pharmaceutical active substance carriers in a separate work step on the connecting parts and, if necessary, only have to be connected to the devices 2 subsequently. This procedure significantly simplifies production.
  • the same depot body and connecting parts can be connected to brackets of different sizes and can therefore be used on cattle of different sizes.
  • the division of the nose clip allows the use of two different depot bodies with a bracket. Such depot bodies can differ in the release characteristics of one and the same active ingredient or in the active ingredients themselves. B. allows the separation of incompatible active ingredients.
  • the connecting parts 3, 4, 16 can be connected in various ways with the bracket ends 2, for. B. by welding, gluing, by a snap closure, also cup-shaped, by a snap fastener, also roller or ball joint-like.
  • the bow ends 2 expediently have incisions as devices for receiving active substances for inserting the connecting parts. These incisions can also be shifted laterally so that their axes form an angle with the longitudinal axes of the temple ends.
  • Brackets and connecting parts can thus be immovably connected or can also be freely connected to one another. With free mobility, the mechanical stress on the nasal mucosa is reduced, which means a further advantage of dividing the nasal clip into brackets with devices and connecting parts.
  • the side of the connecting part which is intended for receiving the depot body and which can also be located directly on the devices can be designed differently.
  • the training depends in particular on the properties and shape of the depot body.
  • rigid depot bodies such as those made of plastics or waxes
  • elastic depot bodies e.g. B. made of silicone rubber, polyurethane rubber, polyacrylate rubber, natural rubber, butyl rubber.
  • connecting parts and depot bodies can consist of the same material and can be produced in one operation. Otherwise, the connecting parts to which the depot body is subsequently applied can first be produced.
  • plastics technology are used for the production of stirrups and connecting parts from plastics, besides injection molding
  • pharmaceutically usual processes for the production of the depot bodies such as casting and solidification and the pressing of wax-like masses, but also casting and subsequent networking. The production processes depend on the properties of the materials provided and must enable production-based production as well as the subsequent assembly of connecting parts with brackets.
  • the side of the connecting part facing the depot body must be designed such that the Depot body can be anchored on the connecting part. This is achieved in that the side facing the depot body 4 of the connecting part z. B. a pin 5 (Fig. 4), which can have one or more grooves (Fig. 5, 6, 7, 10, 12), or several pins (Fig. 9) or that this, for example, as a plate side formed one outer edge, which has an undercut 6 on the inside (FIG. 8).
  • This mechanical consolidation can, for. B. caused by a nonwoven fabric 7.
  • This nonwoven fabric is preferably attached to the pin 5 of the connecting part by welding, riveting 8, nailing, screwing or gluing.
  • FIGS. 9 to 12 Further shapes of the side of the connecting parts which carries the depot body are shown in FIGS. 9 to 12. They allow you to manufacture the connecting parts separately and on these z. B. to apply a prefabricated molding 15, which is then coated with a sleeve 9 and optionally connected in this way to the connecting part (Fig. 11 and Fig. 12). This sleeve can completely or partially encompass the connecting part (FIGS. 11 and 12) and contribute to the depot effect.
  • the depot bodies can also be attached directly to the devices by means of such a sheath, the material of which may be elastic.
  • bores 10 or incisions 11 in the connecting parts according to FIG. 10 promote the escape of air when pouring or spraying on the depot body or when inserting the connecting parts.
  • the cross section of the connecting parts 3, 4, 16 can, for. B. round, elliptical, almond-shaped, oval, teardrop-shaped, oblong or kidney-shaped. It is important that the shape of the connecting parts is chosen so that the depot body can be attached to it and in turn adapt to the nasal vestibule by the angle settings described. Connecting parts and / or depot bodies with non-circular cross sections can form angles with the longitudinal axes of the temple ends, as already mentioned. Such an arrangement ensures the correct anatomical position, and confusion of the depot bodies is avoided.
  • the size of the connecting parts and thus the depot body depends on the weight of the animal and is preferably 15 to 25 mm in diameter.
  • the active ingredient-free applicator takes over the function of side 4 of the connecting part facing the depot body.
  • the applicator thus represents a further embodiment of side 4 of the connecting part (cf. 4a in FIGS. 13 to 17 and 4 in FIGS. 4 to 12 and 18).
  • the applicator can accordingly be understood as part of the depot body and as a further embodiment of side 4 of the connecting part.
  • the clasp is made e.g. B. from a bracket 1 and two connecting parts 3, 16, on which there are two active ingredient-free, dimensionally stable applicators 4a (Fig. 16; 16 not visible).
  • the active ingredient-free, dimensionally stable applicators 4a can also be located directly on the temple ends (FIG. 17), the temple ends being designed directly as active ingredient-free, dimensionally stable applicators 4a.
  • the peculiarities of the angular position, as indicated, remain unaffected.
  • the size and shape of the drug-free, dimensionally stable applicator and drug-containing reservoir depends on the weight of the animal and is also preferably 15 to 25 mm (diameter).
  • the drug-free system described above is preferably manufactured using injection molding technology.
  • the active substance-containing, shape-variable reservoirs 12 are connected to the active substance-free, dimensionally stable applicators 4a and are of the membrane type, ie. that is, the active ingredient or the active ingredients 14, optionally in the form of active ingredient-containing preparations, are surrounded by an active ingredient-free wall 13 and thus represent the reservoir 12.
  • the reservoir 12 (depot) can be a filled, ring-shaped hose which surrounds the applicator 4a (FIG. 13), or a filled cushion (FIG. 14) or a chamber placed on the applicator 4a (FIG. 15).
  • the hoses or the pillows that are prefabricated have elastic, sufficiently tear-resistant walls 13 with a thickness of 0.01 to 2.0 mm, preferably 0.1 to 1.0 mm.
  • the chamber wall is formed on one side by the applicator 4a.
  • the other sides of the chamber are then formed by a prefabricated wall, as already described.
  • the latter can be shaped like a hat and have a reinforced edge 17 (FIG. 15).
  • This edge 17 can correspond to a corresponding groove 18 (FIG. 17) of the applicator 4a. This will ensure a better binding of the z. B. designed as a hose or chamber 12 reservoirs with the applicator.
  • the applicator 4a can have grooves 19 on its surface (FIG. 15) or bores which facilitate the distribution of the active substance (s) or their preparations 14 under the wall 13.
  • the active ingredient (s) or preparations are in solid, liquid, gel-like, etc. form.
  • the reservoirs 12 are after filling with the active ingredient (s) or their preparations in a suitable, known manner, for. B. by welding or gluing, liquid-tight closed and connected to the applicators 4a or the reservoirs are filled subsequently.
  • a biopharmaceutical advantage of the division into a dimensionally stable and dimensionally variable part is that the wall 13 of the part containing the active substance (reservoirs) can be considerably thinner than in the case of a depot body, the wall of which at the same time fulfills a partial function of the mechanical system and may be thicker for its dimensional stability must (9 in Fig. 12).
  • a thinner wall results in easier diffusion and thus easier and higher release of active ingredient, which may be desirable depending on the purpose and type of treatment.
  • the thickness and selection of the wall material influence the active ingredient release in a known manner.
  • As a wall material such. As silicone rubber or copolymers of substituted ethylenes.
  • the active substance-containing content (the active substance itself or a corresponding preparation) of the reservoir used is free of dimensionally stable polymers, which can be advantageous from a pharmaceutical-technical point of view in terms of its manufacturability and durability.
  • the active ingredient-containing, variable-shape reservoirs such as. B.
  • the hoses, pillows or chambers described are extremely flexible, they not only adapt perfectly to the active ingredient-free, dimensionally stable, possibly elastic applicators, but also to the anatomical conditions in the nasal vestibule of the cattle.
  • a nose clip for calves has a smaller bow than a nose clip for adult cattle.
  • the connecting parts in calf clasps may be appropriate for the connecting parts in calf clasps to have a smaller diameter.
  • a nose clip for calves has, for example, a temple length a of 35 mm to 45 mm and a leg depth b of 20 mm to 35 mm, the angle ⁇ is 15 °, the angle ⁇ 15 °.
  • the side of the connecting part which serves to receive the depot body is designed as a plate with a diameter of 15 mm, on which a depot body 15 is fixed.
  • the distance c between the depot bodies is 2 to 7 mm.
  • a nose clip for adult cattle has a temple length a of 55 mm to 70 mm and a thigh depth b of 40 to 55 mm.
  • the angle IX is 15 °, the angle P. 18 °, the diameter of the plate of the connecting part 25 mm.
  • the distance c between the depot bodies is 10 to 20 mm.
  • a nasal clasp for calves or cattle, with the depot bodies being divided, generally has corresponding dimensions.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Description

Die Erfindung betrifft Nasenspangen zur Applikation von Wirkstoffen für prophylaktische oder therapeutische Behandlungen von Rindern.The invention relates to nasal clips for the application of active substances for prophylactic or therapeutic treatments of cattle.

In der DE-C3-2 125464 werden Nasenspangen beschrieben, mit deren Hilfe es möglich ist, Arzneistoffe über einen längeren Zeitraum an die Nasenschleimhaut von Tieren abzugeben. Sie bestehen aus einem Bügel, dessen Enden Einrichtungen zur Aufnahme von in Form von Depotkörpern vorliegenden Wirkstoffen besitzen. Entsprechend einer bevorzugten Ausführungsform verlaufen die Enden der Spange, welche den Wirkstoff tragen, parallel.DE-C3-2 125464 describes nasal clips with the aid of which it is possible to deliver medicinal substances to the nasal mucosa of animals over a longer period of time. They consist of a bracket, the ends of which have devices for receiving active substances in the form of depot bodies. According to a preferred embodiment, the ends of the clasp, which carry the active ingredient, run parallel.

Trageversuche mit Nasenspangen, deren Enden parallel verlaufen und die in der genannten Patentschrift beschrieben werden, über mehrere Wochen bis Monate sowie anatomische Studien am Flotzmaul der Tierart Rind (z. B. am Flotzmaul von Kälbern und erwachsenen Rindern) ließen erkennen, daß im Interesse einer verbesserten Resorption, zur vollständigen Vermeidung von Irritationen auf der Nasenschleimhaut nach langem Tragen und damit zur Sicherstellung einer ungestörten Applikationsdauer besondere Ausführungsformen von Nasenspangen bei Rindern erforderlich sind. Hierbei hat sich gezeigt, daß sich als Applikationsort am besten die Schleimhaut der Nasenscheidewand im Nasenvorhof eignet, zumal hier eine konkave Vertiefung besteht.Attempts to wear nasal clips, the ends of which run parallel and which are described in the patent mentioned, over several weeks to months, and anatomical studies on the snout of the animal species cattle (e.g. on the snout of calves and adult cattle) showed that in the interest of one improved absorption, in order to completely avoid irritation on the nasal mucosa after long wear and thus to ensure an undisturbed application period, special embodiments of nasal clips in cattle are required. It has been shown here that the mucous membrane of the nasal septum in the nasal vestibule is best suited as the application site, especially since there is a concave recess.

Aufgabe der Erfindung ist es, die aufgezeigten Nachteile zu überwinden.The object of the invention is to overcome the disadvantages shown.

Es wurde gefunden, daß eine Nasenspange der aus der DE-C3-2 125464 bekannten Art, bei der die Bügelenden mit den Einrichtungen oder die Oberflächen der Depotkörper gegeneinander geneigt und zueinander gedreht sind, den anatomischen Verhältnissen am Applikationsort, also der Schleimhaut der Nasenscheidewand im Nasenvorhof, weitgehend gerecht wird, eine verbesserte Resorption gewährleistet und bei einer Applikationszeit von mehreren Wochen und länger keine pathologischen Veränderungen am Applikationsort hervorruft.It has been found that a nose clip of the type known from DE-C3-2 125464, in which the temple ends with the devices or the surfaces of the depot bodies are inclined towards one another and rotated relative to one another, the anatomical conditions at the application site, i.e. the mucous membrane of the nasal septum Nasal atrium, largely does justice to improved absorption and does not cause any pathological changes at the application site after an application time of several weeks or longer.

Die Erfindung betrifft daher eine Nasenspange zur prophylaktischen oder therapeutischen Behandlung von Rindern, bestehend aus einem Bügel, dessen Enden Einrichtungen zur Aufnahme von in Form von Depotkörpern vorliegenden Wirkstoffen besitzen, und ist dadurch gekennzeichnet, daß entweder die Bügelenden mit den Einrichtungen oder die Oberflächen der Depotkörper gegeneinander geneigt und zueinander gedreht sind. Die Depotkörper können aufgeteilt sein in einen wirkstofffreien, formbeständigen Applikator und ein mit ihm verbundenes, wirkstoffhaltiges, formvariables Reservoir.The invention therefore relates to a nose clip for the prophylactic or therapeutic treatment of cattle, consisting of a hanger, the ends of which have devices for receiving active substances in the form of depot bodies, and is characterized in that either the temple ends with the devices or the surfaces of the depot body inclined towards each other and rotated towards each other. The depot body can be divided into an active substance-free, dimensionally stable applicator and an associated, active substance-containing, variable shape reservoir.

Die Einrichtungen oder die Oberflächen der Depotkörper sind gegeneinander geneigt und zueinander gedreht. Durch diese Winkelstellungen werden die beim Tragen der dem Stand der Technik entsprechenden Nasenspangen mit parallel verlaufenden Enden und folglich auch parallel verlaufenden Oberflächen der Depotkörper beobachteten Nachteile überwunden. Eine sichere Langzeitbehandlung ohne zusätzlichen Aufwand ist mit der erfindungsgemäßen Nasenspange möglich.The devices or the surfaces of the depot bodies are inclined relative to one another and rotated relative to one another. These angular positions overcome the disadvantages observed when wearing the nose clips corresponding to the prior art with parallel ends and consequently also parallel surfaces of the depot bodies. A safe long-term treatment without additional effort is possible with the nose clip according to the invention.

In den vorstehenden und nachfolgenden Ausführungen wird, wenn nichts anderes angegeben ist, unter »Rindern« die Tierart Rind verstanden.In the above and following explanations, unless otherwise stated, "cattle" means the animal species cattle.

Die Erfindung betrifft insbesondere eine Nasenspange, die aus einem federnden, U-förmigen Bügel besteht, dessen Enden gegeneinander geneigt und zueinander gedreht sind und Einrichtungen zur Aufnahme von Wirkstoffen in Form von Depotkörpern besitzen.The invention particularly relates to a nose clip which consists of a resilient, U-shaped bracket, the ends of which are inclined and rotated relative to one another and have devices for receiving active substances in the form of depot bodies.

Die Fig.1 1 bis 18 stellen Beispiele der erfindungsgemäßen Nasenspange bzw. verschiedene Ausführungsformen von Verbindungsteilen mit und ohne Depotkörper bzw. Applikatoren und Reservoiren dar, und zwar zeigt

  • Fig. 1 die Ansicht des Bügels einer Nasenspange von unten,
  • Fig. 2 die Ansicht des Bügels einer Nasenspange von der Seite,
  • Fig. 3 die Ansicht einer Nasenspange von vorn, teilweise geschnitten,
  • Fig. 4 bis 15 verschiedene Ausführungsformen von Verbindungsteilen mit und ohne Depotkörper bzw. Applikatoren und Reservoiren,
  • Fig. 16 und 17 die Ansicht einer Nasenspange von unten ohne Reservoir,
  • Fig. 18 die Ansicht einer Nasenspange von unten mit Depotkörper.
11 to 18 represent examples of the nasal clip according to the invention or different embodiments of connecting parts with and without depot bodies or applicators and reservoirs, and that shows
  • 1 is a view of the bracket of a nose clip from below,
  • 2 is a side view of the bracket of a nose clip,
  • 3 shows the view of a nose clip from the front, partly in section,
  • 4 to 15 different embodiments of connecting parts with and without depot bodies or applicators and reservoirs,
  • 16 and 17 the view of a nose clip from below without a reservoir,
  • 18 shows the view of a nose clip from below with a depot body.

Der Bügel 1 der Nasenspange muß eine Festigkeit besitzen, die den anatomisch richtigen Sitz der Depotkörper während der gesamten Tragezeit ermöglicht. Auf der anderen Seite muß er elastisch genug sein, um das Einsetzen und Herausnehmen der Nasenspange zu ermöglichen und um sich in gewissem Grade dem Wachstum beispielsweise eines Kalbes während der Tragezeit der Nasenspange anpassen zu können.The bracket 1 of the nose clip must have a strength that enables the anatomically correct fit of the depot body during the entire wearing time. On the other hand, it has to be elastic enough to enable the insertion and removal of the nasal clip and to be able to adapt to a certain extent to the growth of, for example, a calf during the wearing period of the nasal clip.

Die optimale Kraft und Relaxation bei einer Aufbiegung des Bügels von 2,5 mm wurden durch Kraft-Weg-Messungen und Vergleichen mit den Ergebnissen von Trageversuchen an Kälbern und erwachsenen Rindern ermittelt. Es hat sich gezeigt, daß ein Bügel mit einer Kraft von 0,5 N bis 4 N, welche nach dem Trageversuch nur wenig geringer ist, besonders geeignet ist. Die Kraft wurde auf einer Materialprüfmaschine mit einer Vorschubgeschwindigkeit von 10 mm/min auf einem Weg von 2,5 mm bei einer Temperatur von bestimmt.The optimal strength and relaxation when the bracket was bent by 2.5 mm were determined by force-displacement measurements and comparison with the results of wearing tests on calves and adult cattle. It has been shown that a bracket with a force of 0.5 N to 4 N, which is only slightly less after the wearing test, is particularly suitable. The force was determined on a material testing machine with a feed rate of 10 mm / min on a path of 2.5 mm at a temperature of

Als Material für die Ausführung des Bügels eignen sich Metalle oder Kunststoffe, wie z. B. Polyamid, Polystyrol, bevorzugt Polypropylen und Polyacetal (Polyoximethylen). Die Stärke des Bügels schwankt in gewissen Grenzen und hängt u. a. ab vom Material.As a material for the execution of the bracket, metals or plastics, such as. B. polyamide, polystyrene, preferably polypropylene and polyacetal (polyoxymethylene). The thickness of the bracket varies within certain limits and depends on the material.

Die Bügelenden besitzen Einrichtungen 2 zur Aufnahme von Wirkstoffen in Form von Depotkörpern. Bei der bevorzugten Ausführungsform der Erfindung sind die Einrichtungen gegeneinander geneigt und bilden einen Neigungswinkel α (Fig. 1), der größer als 0° ist. Er beträgt vorzugsweise 5° bis 30°, insbesondere 10° bis 23°.The temple ends have devices 2 for receiving active substances in the form of depot bodies. In the preferred embodiment of the invention, the devices are inclined towards one another and form an inclination angle α (FIG. 1) which is greater than 0 °. It is preferably 5 ° to 30 °, in particular 10 ° to 23 °.

Die Einrichtungen sind außerdem zueinander gedreht und weisen einen Torsionswinkel β (Fig. 3) auf, der vorzugsweise 2° bis 45° und insbesondere 8° bis 28° beträgt. Er entsteht durch Torsion der als Einrichtungen ausgebildeten Bügelenden selbst oder durch Torsion der Verbindungsteile.The devices are also rotated relative to one another and have a torsion angle β (FIG. 3) which is preferably 2 ° to 45 ° and in particular 8 ° to 28 °. It arises from torsion of the temple ends designed as devices themselves or from torsion of the connecting parts.

Die Einrichtungen mit den Winkeln x und ß gewährleisten erst die optimale Anpassung der Nasenspange an die anatomischen Verhältnisse des Nasenvorhofs. Der Torsionswinkel ß am Bügelende vermeidet Irrtümer beim Zusammensetzen der Nasenspange und beim Anbringen am Applikationsort.The devices with the angles x and ß ensure the optimal adaptation of the nasal clip to the anatomical conditions of the nasal vestibule. The torsion angle ß at the temple end prevents errors when assembling the nose clip and when attaching it to the application site.

Falls die auf den Einrichtungen befindlichen Depotkörper Oberflächen besitzen, die gegeneinander geneigt und zueinander gedreht sind, werden die Winkel IX und ß von den Depotkörpern gebildet, d. h., die Winkel werden aufgrund besonderer Formen der Depotkörper gebildet.If the depot bodies located on the devices have surfaces which are inclined and rotated relative to one another, the angles IX and β are formed by the depot bodies, i. that is, the angles are formed on the basis of special shapes of the depot bodies.

Die erfindungsgemäße Nasenspange wird zur Applikation von Wirkstoffen verwendet, wobei die Applikation über einen langen Zeitraum (z. B. mehrere Wochen) erfolgt. Der Wirkstoff liegt daher in Form eines Depotkörpers vor, wobei der Wirkstoff als solcher ein Depotkörper sein kann oder mit einem die Wirkstoff-Freigabe verzögernden Trägerstoff den Depotkörper bildet. Der Depotkörper kann auch aus einem Wirkstoff-Formling mit umgebender Hülle bestehen.The nose clip according to the invention is used for the application of active substances, the application taking place over a long period of time (e.g. several weeks). The active substance is therefore in the form of a depot body, the active substance as such being a depot body or forming the depot body with a carrier which delays the release of the active substance. The depot body can also consist of an active substance molding with a surrounding shell.

Die Depotkörper können direkt auf den Einrichtungen 2 fixiert werden. Vorzugsweise befindet sich an den Einrichtungen 2 je ein Verbindungsteil 3, 4, 16 (Fig. 4 bis 12), das die Verbindung zwischen den Einrichtungen am Bügelende und dem Depotkörper herstellt. Die den Einrichtungen zugewandte Seite des Verbindungsteils hat vorzugsweise die in Fig. 4 bis 12 wiedergegebene Form 3, 4, 16. Durchmesser, Dicke und Form der plattenförmigen Teile 3 und 4 des Verbindungsteils müssen nicht identisch sein.The depot bodies can be fixed directly on the devices 2. A connection part 3, 4, 16 (FIGS. 4 to 12), which establishes the connection between the devices at the temple end and the depot body, is preferably located on the devices 2. The side of the connecting part facing the devices preferably has the shape 3, 4, 16 shown in FIGS. 4 to 12. The diameter, thickness and shape of the plate-shaped parts 3 and 4 of the connecting part need not be identical.

Vorteile der erfindungsgemäßen Ausführungsform liegen darin, daß die Depotkörper als pharmazeutische Wirkstoffträger in einem getrennten Arbeitsgang auf den Verbindungsteilen hergestellt werden können und gegebenenfalls erst nachträglich mit den Einrichtungen 2 verbunden zu werden brauchen. Dieses Vorgehen erleichtert die produktionsmäßige Herstellung wesentlich.Advantages of the embodiment according to the invention lie in the fact that the depot bodies can be produced as pharmaceutical active substance carriers in a separate work step on the connecting parts and, if necessary, only have to be connected to the devices 2 subsequently. This procedure significantly simplifies production.

Ein weiterer Vorteil liegt darin, daß dieselben Depotkörper und Verbindungsteile mit Bügeln unterschiedlicher Größe verbunden und somit an Rindern verschiedener Größe angewendet werden können. Schließlich erlaubt die Unterteilung der Nasenspange die Anwendung von zwei unterschiedlichen Depotkörpern mit einem Bügel. Solche Depotkörper können sich in der Freigabecharakteristik ein und desselben Wirkstoffes oder in den Wirkstoffen selbst unterscheiden, was z. B. die Trennung inkompatibler Wirkstoffe ermöglicht.Another advantage is that the same depot body and connecting parts can be connected to brackets of different sizes and can therefore be used on cattle of different sizes. Finally, the division of the nose clip allows the use of two different depot bodies with a bracket. Such depot bodies can differ in the release characteristics of one and the same active ingredient or in the active ingredients themselves. B. allows the separation of incompatible active ingredients.

Die Verbindungsteile 3, 4, 16 können auf verschiedene Weise mit den Bügelenden 2 verbunden werden, z. B. durch Verschweißen, Kleben, durch einen Schnappverschluß, auch napfförmig, durch einen Druckknopfverschluß, auch walzen- oder kugelgelenkartig. Die Bügelenden 2 weisen zweckmäßigerweise als Einrichtungen zur Aufnahme von Wirkstoffen Einschnitte auf zur Einschiebung der Verbindungsteile. Diese Einschnitte können auch seitlich verschoben sein, so daß ihre Achsen zu den Längsachsen der Bügelenden einen Winkel bilden. Bügel und Verbindungsteile können somit unbeweglich verbunden oder auch freibeweglich miteinander verbunden sein. Bei freier Beweglichkeit wird die mechanische Beanspruchung der Nasenschleimhaut vermindert, was ein weiterer Vorteil der Unterteilung der Nasenspange in Bügel mit Einrichtungen und Verbindungsteilen bedeutet.The connecting parts 3, 4, 16 can be connected in various ways with the bracket ends 2, for. B. by welding, gluing, by a snap closure, also cup-shaped, by a snap fastener, also roller or ball joint-like. The bow ends 2 expediently have incisions as devices for receiving active substances for inserting the connecting parts. These incisions can also be shifted laterally so that their axes form an angle with the longitudinal axes of the temple ends. Brackets and connecting parts can thus be immovably connected or can also be freely connected to one another. With free mobility, the mechanical stress on the nasal mucosa is reduced, which means a further advantage of dividing the nasal clip into brackets with devices and connecting parts.

Die zur Aufnahme des Depotkörpers bestimmte Seite des Verbindungsteils, die sich auch direkt auf den Einrichtungen befinden kann, kann verschieden ausgebildet sein. Die Ausbildung hängt insbesondere von den Eigenschaften und der Form des Depotkörpers ab.The side of the connecting part which is intended for receiving the depot body and which can also be located directly on the devices can be designed differently. The training depends in particular on the properties and shape of the depot body.

Zu unterscheiden sind hier starre Depotkörper, wie solche aus Kunststoffen oder Wachsen, von elastischen Depotkörpern, z. B. aus Silicon-Kautschuk, Polyurethan-Kautschuk, Polyacrylat-Kautschuk, Natur-Kautschuk, Butyl-Kautschuk. Unter der Voraussetzung geeigneter Eigenschaften können Verbindungsteile und Depotkörper aus dem gleichen Material bestehen und in einem Arbeitsgang hergestellt werden. Andernfalls können zunächst die Verbindungsteile hergestellt werden, auf die nachfolgend der Depotkörper aufgebracht wird. Während für die Herstellung von Bügeln und Verbindungsteilen aus Kunststoffen die in der Kunststofftechnik üblichen Herstellungsverfahren angewendet werden, bieten sich für die Herstellung der Depotkörper neben Spritzgießen auch die pharmazeutisch üblichen Verfahren, wie das Gießen und Erstarrenlassen und das Aufpressen von wachsähnlichen Massen, aber auch das Gießen und nachfolgendes Vernetzen an. Die Verfahren der Herstellung sind von den Eigenschaften der vorgesehenen Materialien abhängig und müssen eine produktionsmäßige Herstellung wie auch den nachfolgenden Zusammenbau von Verbindungsteilen mit Bügeln ermöglichen.A distinction is made here between rigid depot bodies, such as those made of plastics or waxes, from elastic depot bodies, e.g. B. made of silicone rubber, polyurethane rubber, polyacrylate rubber, natural rubber, butyl rubber. Provided that suitable properties are provided, connecting parts and depot bodies can consist of the same material and can be produced in one operation. Otherwise, the connecting parts to which the depot body is subsequently applied can first be produced. While the usual manufacturing processes used in plastics technology are used for the production of stirrups and connecting parts from plastics, besides injection molding, there are also the pharmaceutically usual processes for the production of the depot bodies, such as casting and solidification and the pressing of wax-like masses, but also casting and subsequent networking. The production processes depend on the properties of the materials provided and must enable production-based production as well as the subsequent assembly of connecting parts with brackets.

Falls Depotkörper und Verbindungsteile aus unterschiedlichen Materialien bestehen und zu verschiedenen Zeiten hergestellt werden, muß die dem Depotkörper zugewandte Seite des Verbindungsteils so ausgebildet sein, daß der Depotkörper auf dem Verbindungsteil verankert werden kann. Dies wird dadurch erreicht, daß die dem Depotkörper zugewandte Seite 4 des Verbindungsteils z. B. einen Stift 5 (Fig. 4), welcher eine oder mehrere Rillen aufweisen kann (Fig. 5, 6, 7, 10, 12), oder mehrere Stifte (Fig. 9) besitzt oder daß diese beispielsweise als Platte ausgebildete Seite einen äußeren Rand, welcher innen einen Unterschnitt 6 aufweist, besitzt (Fig. 8).If depot body and connecting parts consist of different materials and are manufactured at different times, the side of the connecting part facing the depot body must be designed such that the Depot body can be anchored on the connecting part. This is achieved in that the side facing the depot body 4 of the connecting part z. B. a pin 5 (Fig. 4), which can have one or more grooves (Fig. 5, 6, 7, 10, 12), or several pins (Fig. 9) or that this, for example, as a plate side formed one outer edge, which has an undercut 6 on the inside (FIG. 8).

Depotkörper, die während ihrer Anwendung infolge Elution mechanisch geschwächt oder die zur Wirkstoff-Freigabe abgetragen werden (Erosion), können das Einbringen einer mechanischen Verfestigung erfordern. Diese mechanische Verfestigung kann z. B. durch ein Faservlies 7 bewirkt werden. Dieses Faservlies wird vorzugsweise an dem Stift 5 des Verbindungsteils durch Verschweißen, Vernieten 8, Vernageln, Verschrauben oder Verkleben befestigt.Depot bodies that are mechanically weakened as a result of elution or that are removed to release the active ingredient (erosion) may require mechanical strengthening to be introduced. This mechanical consolidation can, for. B. caused by a nonwoven fabric 7. This nonwoven fabric is preferably attached to the pin 5 of the connecting part by welding, riveting 8, nailing, screwing or gluing.

Weitere Formen der Seite der Verbindungsteile, die den Depotkörper trägt, sind in den Fig. 9 bis 12 dargestellt. Sie ermöglichen, die Verbindungsteile getrennt herzustellen und auf diese z. B. einen vorgefertigten Formling 15 aufzubringen, der dann mit einer Hülle 9 ummantelt und gegebenenfalls auf diese Weise mit dem Verbindungsteil verbunden wird (Fig. 11 und Fig. 12). Diese Hülle kann das Verbindungsteil ganz oder teilweise umfassen (Fig. 11 und Fig. 12) und zum Depoteffekt beitragen. Die Befestigung von Depotkörpern kann auch direkt an den Einrichtungen ebenfalls durch eine solche Hülle erfolgen, deren Material gegebenenfalls elastisch ist.Further shapes of the side of the connecting parts which carries the depot body are shown in FIGS. 9 to 12. They allow you to manufacture the connecting parts separately and on these z. B. to apply a prefabricated molding 15, which is then coated with a sleeve 9 and optionally connected in this way to the connecting part (Fig. 11 and Fig. 12). This sleeve can completely or partially encompass the connecting part (FIGS. 11 and 12) and contribute to the depot effect. The depot bodies can also be attached directly to the devices by means of such a sheath, the material of which may be elastic.

Je nach Gießtechnik begünstigen Bohrungen 10 oder Einschnitte 11 in den Verbindungsteilen gemäß Fig. 10 das Entweichen von Luft beim Aufgießen oder Aufspritzen der Depotkörper bzw. beim Einsetzen der Verbindungsteile.Depending on the casting technique, bores 10 or incisions 11 in the connecting parts according to FIG. 10 promote the escape of air when pouring or spraying on the depot body or when inserting the connecting parts.

Der Querschnitt der Verbindungsteile 3, 4, 16 kann z. B. rund, elliptisch, mandelförmig, oval, tropfenförmig, oblong oder nierenförmig sein. Wichtig ist, daß die Form der Verbindungsteile so gewählt wird, daß die Depotkörper auf diesen befestigt werden können und sich ihrerseits wieder durch die beschriebenen Winkeleinstellungen dem Nasenvorhof anpassen. Verbindungsteile und/oder Depotkörper mit nicht kreisrunden Querschnitten können mit den Längsachsen der Bügelenden Winkel bilden, wie bereits erwähnt. Eine solche Anordnung gewährleistet die richtige anatomische Stellung, und eine Verwechslung der Depotkörper wird vermieden.The cross section of the connecting parts 3, 4, 16 can, for. B. round, elliptical, almond-shaped, oval, teardrop-shaped, oblong or kidney-shaped. It is important that the shape of the connecting parts is chosen so that the depot body can be attached to it and in turn adapt to the nasal vestibule by the angle settings described. Connecting parts and / or depot bodies with non-circular cross sections can form angles with the longitudinal axes of the temple ends, as already mentioned. Such an arrangement ensures the correct anatomical position, and confusion of the depot bodies is avoided.

Die Größe der Verbindungsteile und damit der Depotkörper hängt vom Gewicht des Tieres ab und beträgt bevorzugt 15 bis 25 mm Durchmesser.The size of the connecting parts and thus the depot body depends on the weight of the animal and is preferably 15 to 25 mm in diameter.

Falls die Depotkörper aufgeteilt sind in einen wirkstofffreien, formbeständigen, gegebenenfalls elastischen Applikator 4a und ein wirkstoffhaltiges, formvariables Reservoir 12, so übernimmt der wirkstofffreie Applikator die Funktion der dem Depotkörper zugewandten Seite 4 des Verbindungsteils. Von der Funktion aus betrachtet, stellt der Applikator also eine weitere Ausführungsform der Seite 4 des Verbindungsteils dar (vgl. 4a in Fig. 13 bis 17 und 4 in Fig. 4 bis 12 und 18). Der Applikator kann demnach als Teil des Depotkörpers und als weitere Ausgestaltung der Seite 4 des Verbindungsteils verstanden werden.If the depot body is divided into an active ingredient-free, dimensionally stable, optionally elastic applicator 4a and an active ingredient-containing, variable shape reservoir 12, the active ingredient-free applicator takes over the function of side 4 of the connecting part facing the depot body. In terms of function, the applicator thus represents a further embodiment of side 4 of the connecting part (cf. 4a in FIGS. 13 to 17 and 4 in FIGS. 4 to 12 and 18). The applicator can accordingly be understood as part of the depot body and as a further embodiment of side 4 of the connecting part.

Bei der erwähnten Ausführungsform besteht die Spange z. B. aus einem Bügel 1 und zwei Verbindungsteilen 3, 16, auf denen sich zwei wirkstofffreie, formbeständige Applikatoren 4a (Fig. 16; 16 nicht sichtbar) befinden. Die wirkstofffreien, formbeständigen Applikatoren 4a können sich auch direkt auf den Bügelenden befinden (Fig. 17), wobei die Bügelenden direkt als wirkstofffreie, formbeständige Applikatoren 4a ausgebildet sind. Die Besonderheiten der Winkelstellung, wie angegeben, bleiben unberührt. Die Größe und Form von wirkstofffreiem, formbeständigem Applikator und wirkstoffhaltigem Reservoir hängt vom Gewicht des Tieres ab und beträgt ebenfalls vorzugsweise 15 bis 25 mm (Durchmesser).In the embodiment mentioned, the clasp is made e.g. B. from a bracket 1 and two connecting parts 3, 16, on which there are two active ingredient-free, dimensionally stable applicators 4a (Fig. 16; 16 not visible). The active ingredient-free, dimensionally stable applicators 4a can also be located directly on the temple ends (FIG. 17), the temple ends being designed directly as active ingredient-free, dimensionally stable applicators 4a. The peculiarities of the angular position, as indicated, remain unaffected. The size and shape of the drug-free, dimensionally stable applicator and drug-containing reservoir depends on the weight of the animal and is also preferably 15 to 25 mm (diameter).

Das vorstehend beschriebene wirkstofffreie System wird bevorzugt in Spritzgußtechnik hergestellt.The drug-free system described above is preferably manufactured using injection molding technology.

Die wirkstoffhaltigen, formvariablen Reservoire 12 werden mit den wirkstofffreien, formbeständigen Applikatoren 4a verbunden und sind vom Membran-Typ, d. h., der Wirkstoff oder die Wirkstoffe 14, gegebenenfalls in Form von wirkstoffhaltigen Zubereitungen, werden von einer wirkstofffreien Wand 13 umgeben und stellen somit das Reservoir 12 dar.The active substance-containing, shape-variable reservoirs 12 are connected to the active substance-free, dimensionally stable applicators 4a and are of the membrane type, ie. that is, the active ingredient or the active ingredients 14, optionally in the form of active ingredient-containing preparations, are surrounded by an active ingredient-free wall 13 and thus represent the reservoir 12.

Das Reservoir 12 (Depot) kann ein gefüllter, ringförmiger Schlauch sein, der den Applikator 4a umschließt (Fig. 13), oder ein gefülltes Kissen (Fig. 14) oder eine auf den Applikator 4a aufgesetzte Kammer sein (Fig. 15).The reservoir 12 (depot) can be a filled, ring-shaped hose which surrounds the applicator 4a (FIG. 13), or a filled cushion (FIG. 14) or a chamber placed on the applicator 4a (FIG. 15).

Die Schläuche bzw. die Kissen, die vorgefertigt werden, besitzen elastische, ausreichend reißfeste Wände 13 mit einer Dicke von 0,01 bis 2,0 mm, bevorzugt 0,1 bis 1,0 mm. Die Kammerwand wird einseitig von dem Applikator 4a gebildet. Die anderen Seiten der Kammer werden dann von einer vorgefertigten Wand, wie sie bereits beschrieben ist, gebildet. Letztere kann hütchenförmig geformt sein und einen verstärkten Rand 17 besitzen (Fig. 15). Dieser Rand 17 kann mit einer entsprechenden Nut 18 (Fig. 17) des Applikators 4a korrespondieren. Hierdurch wird eine bessere Bindung des z. B. als Schlauch oder Kammer ausgebildeten Reservoirs 12 mit dem Applikator gewährleistet. Der Applikator 4a kann auf seiner Oberfläche Rillen 19 haben (Fig. 15) oder Bohrungen, die das Verteilen des/der Wirkstoffe(s) oder ihrer Zubereitungen 14 unter der Wand 13 erleichtern.The hoses or the pillows that are prefabricated have elastic, sufficiently tear-resistant walls 13 with a thickness of 0.01 to 2.0 mm, preferably 0.1 to 1.0 mm. The chamber wall is formed on one side by the applicator 4a. The other sides of the chamber are then formed by a prefabricated wall, as already described. The latter can be shaped like a hat and have a reinforced edge 17 (FIG. 15). This edge 17 can correspond to a corresponding groove 18 (FIG. 17) of the applicator 4a. This will ensure a better binding of the z. B. designed as a hose or chamber 12 reservoirs with the applicator. The applicator 4a can have grooves 19 on its surface (FIG. 15) or bores which facilitate the distribution of the active substance (s) or their preparations 14 under the wall 13.

Der/die Wirkstoff(e) bzw. Zubereitungen liegen in fester, flüssiger, gelartiger usw. Form vor.The active ingredient (s) or preparations are in solid, liquid, gel-like, etc. form.

Die Reservoire 12 werden nach dem Füllen mit dem/den Wirkstoff(en) oder ihren Zubereitungen in geeigneter, bekannter Weise, z. B. durch Verschweißen oder Verkleben, flüssigkeitsdicht verschlossen und mit den Applikatoren 4a verbunden oder die Reservoire werden nachträglich gefüllt.The reservoirs 12 are after filling with the active ingredient (s) or their preparations in a suitable, known manner, for. B. by welding or gluing, liquid-tight closed and connected to the applicators 4a or the reservoirs are filled subsequently.

Ein biopharmazeutischer Vorteil der Aufteilung in einen formbeständigen und formvariablen Teil besteht darin, daß die Wand 13 des wirkstoffhaltigen Teils (Reservoirs) wesentlich dünner sein kann als bei einem Depotkörper, dessen Wand zugleich eine Teilfunktion des mechanischen Systems erfüllt und um ihrer Formbeständigkeit willen gegebenenfalls dicker sein muß (9 in Fig. 12). Eine dünnere Wand bewirkt eine leichtere Diffusion und damit eine leichtere sowie höhere Wirkstoff-Freigabe, was je nach Zweck und Art der Behandlung erwünscht sein kann. Dicke und Auswahl des Wandmaterials beeinflussen die Wirkstoff-Freigabe in bekannter Weise. Als Wandmaterial eignen sich z. B. Silicon-Kautschuk oder Copolymere substituierter Äthylene.A biopharmaceutical advantage of the division into a dimensionally stable and dimensionally variable part is that the wall 13 of the part containing the active substance (reservoirs) can be considerably thinner than in the case of a depot body, the wall of which at the same time fulfills a partial function of the mechanical system and may be thicker for its dimensional stability must (9 in Fig. 12). A thinner wall results in easier diffusion and thus easier and higher release of active ingredient, which may be desirable depending on the purpose and type of treatment. The thickness and selection of the wall material influence the active ingredient release in a known manner. As a wall material such. As silicone rubber or copolymers of substituted ethylenes.

Im Gegensatz zu einem wirkstoffhaltigen Teil vom Matrix-Typ ist der wirkstoffhaltige Inhalt (der Wirkstoff selbst oder eine entsprechende Zubereitung) des verwendeten Reservoirs frei von formbeständigen Polymeren, was hinsichtlich der Herstellbarkeit und Haltbarkeit pharmazeutisch-technisch vorteilhaft sein kann.In contrast to an active substance-containing part of the matrix type, the active substance-containing content (the active substance itself or a corresponding preparation) of the reservoir used is free of dimensionally stable polymers, which can be advantageous from a pharmaceutical-technical point of view in terms of its manufacturability and durability.

Alle wirkstofffreien Teile sowie gegebenenfalls das wirkstoffhaltige Reservoir können vorgefertigt werden. Sie werden anschließend miteinander verbunden. Dies erlaubt größtmögliche Freiheit in der Auswahl der Materialien sowohl für das gesamte wirkstofffreie System als auch für den wirkstoffhaltigen Teil der Nasenspange.All drug-free parts and, if applicable, the drug-containing reservoir can be prefabricated. You will then be connected. This allows the greatest possible freedom in the selection of materials both for the entire drug-free system and for the drug-containing part of the nose clip.

Da die wirkstoffhaltigen, formvariablen Reservoire, wie z. B. die beschriebenen Schläuche, Kissen oder Kammern, außerordentlich flexibel sind, passen sie sich nicht nur hervorragend den wirkstofffreien, formbeständigen, gegebenenfalls elastischen Applikatoren an, sondern auch den anatomischen Verhältnissen im Nasenvorhof der Rinder.Since the active ingredient-containing, variable-shape reservoirs, such as. B. the hoses, pillows or chambers described are extremely flexible, they not only adapt perfectly to the active ingredient-free, dimensionally stable, possibly elastic applicators, but also to the anatomical conditions in the nasal vestibule of the cattle.

Um zu vermeiden, daß die Tiere die Nasenspange durch Scheuern an Gegenständen herausreißen können, ist es zweckmäßig, daß der Bügel dem Flotzmaul direkt anliegt. Demnach besitzt eine Nasenspange für Kälber einen kleineren Bügel als eine Nasenspange für ausgewachsene Rinder. Außerdem kann es zweckmäßig sein, daß die Verbindungsteile bei Spangen für Kälber einen kleineren Durchmesser aufweisen.In order to avoid that the animals can tear out the nose clip by rubbing against objects, it is expedient for the bracket to lie directly against the snout's mouth. Accordingly, a nose clip for calves has a smaller bow than a nose clip for adult cattle. In addition, it may be appropriate for the connecting parts in calf clasps to have a smaller diameter.

Eine Nasenspange für Kälber (Fig. 18) hat beispielsweise eine Bügellänge a von 35 mm bis 45 mm und eine Schenkeltiefe b von 20 mm bis 35 mm, der Winkel α beträgt 15°, der Winkel β 15°. Die Seite des Verbindungsteils, die zur Aufnahme des Depotkörpers dient, ist als Platte mit einem Durchmesser von 15 mm ausgebildet, auf welcher ein Depotkörper 15 fixiert ist. Der Abstand c zwischen den Depotkörpern beträgt 2 bis 7 mm.A nose clip for calves (Fig. 18) has, for example, a temple length a of 35 mm to 45 mm and a leg depth b of 20 mm to 35 mm, the angle α is 15 °, the angle β 15 °. The side of the connecting part which serves to receive the depot body is designed as a plate with a diameter of 15 mm, on which a depot body 15 is fixed. The distance c between the depot bodies is 2 to 7 mm.

Eine Nasenspange für ausgewachsene Rinder hat eine Bügellänge a von 55 mm bis 70 mm und eine Schenkeltiefe b von 40 bis 55 mm. Der Winkel IX beträgt 15°, der Winkel P. 18°, der Durchmesser der Platte des Verbindungsteils 25 mm. Der Abstand c zwischen den Depotkörpern beträgt 10 bis 20 mm.A nose clip for adult cattle has a temple length a of 55 mm to 70 mm and a thigh depth b of 40 to 55 mm. The angle IX is 15 °, the angle P. 18 °, the diameter of the plate of the connecting part 25 mm. The distance c between the depot bodies is 10 to 20 mm.

Eine Nasenspange für Kälber bzw. Rinder, wobei die Depotkörper aufgeteilt sind, besitzt prinzipiell entsprechende Abmessungen.A nasal clasp for calves or cattle, with the depot bodies being divided, generally has corresponding dimensions.

Claims (12)

1. A nose-clip for the prophylactic or therapeutic treatment of cattle, comprising a bow (1) whose ends possess means (2) for taking up active ingredients being in the form of depot bodies (15), wherein either said ends of the bow with said means (2) or the surfaces of the depot bodies (15) are inclined towards each other (α) and turned to face each other (β).
2. Nose-clip as claimed in claim 1, wherein said means (2) form an inclination angle IX from 5 to 30°, preferably 10 to 23° (Fig. 1).
3. Nose-clip as claimed in claim 1, wherein said means (2) form a torsion angle β from 2 to 45°, preferably 8 to 28° (Fig. 3).
4. Nose-clip as claimed in claim 1, wherein the depot bodies (15) are fixed directly onto said means (2).
5. Nose-clip as claimed in claim 1, wherein said means (2) are provided with connecting parts (3, 4,16) for fixing the depot bodies (Fig. 4 to 12).
6. Nose-clip as claimed in claims 1 and 5, wherein said depot bodies (15) are fixed on said means (2) at the end of the bow or on the connecting parts (3, 4, 16) by means of an optionally elastic jacket (9), which surrounds the depot bodies (15) and said means (2) or the depot bodies (15) and the connecting parts (3,4, 16) completely or partially (Fig. 11 and 12).
7. Nose-clip as claimed in claim 1, wherein the depot bodies are subdivided into a dimensionally stable, applicator (4a) free from active ingredient and a dimensionally variable reservoir (12) containing active ingredient, the reservoir being connected with the applicator.
8. Nose-clip as claimed in claim 7, consisting of a bow (1) whose ends are shaped to act as applicators (4a) (Fig. 17).
9. Nose-clip as claimed in claim 7, wherein the reservoirs (12) are shaped as tubes or pads surrounded by an elastic wall (13) (Fig. 13 and 14).
10. Nose-clip as claimed in claim 7, wherein the reservoirs (12) are shaped as chambers, one wail whereof is formed by applicator (4a) and the other walls whereof are formed by an elastic wall (13) (Fig. 15).
11. Nose-clip as claimed in claim 7, wherein the applicators (4a) have a groove (18) (Fig. 17).
12. Nose-clip as claimed in claim 7, wherein the applicators (4a) are provided with grooves (19) or with bores at their surface (Fig. 15).
EP80101337A 1979-03-17 1980-03-14 Nose clip for the prophylactic or therapeutic treatment of cattle Expired EP0016431B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT80101337T ATE5229T1 (en) 1979-03-17 1980-03-14 NOSE CLIP FOR PROPHYLACTIC OR THERAPEUTIC TREATMENT OF CATTLE.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19792910629 DE2910629A1 (en) 1979-03-17 1979-03-17 Nose clip for medicating cattle - has receiving surfaces for medicinal bodies mutually inclined and twisted
DE2910629 1979-03-17
DE2926283 1979-06-29
DE19792926283 DE2926283A1 (en) 1979-06-29 1979-06-29 Nose clip for cattle treatment - has bow holder for plug fitments with reservoir sleeves or pads, with bows angled together at ends for firm fitting

Publications (2)

Publication Number Publication Date
EP0016431A1 EP0016431A1 (en) 1980-10-01
EP0016431B1 true EP0016431B1 (en) 1983-11-09

Family

ID=25778279

Family Applications (1)

Application Number Title Priority Date Filing Date
EP80101337A Expired EP0016431B1 (en) 1979-03-17 1980-03-14 Nose clip for the prophylactic or therapeutic treatment of cattle

Country Status (16)

Country Link
US (1) US4369783A (en)
EP (1) EP0016431B1 (en)
AR (1) AR223515A1 (en)
AU (1) AU538641B2 (en)
CA (1) CA1136499A (en)
DE (1) DE3065495D1 (en)
DK (1) DK113280A (en)
EG (1) EG15007A (en)
ES (1) ES489393A1 (en)
FI (1) FI800782A (en)
HU (1) HU178841B (en)
IE (1) IE49189B1 (en)
IL (1) IL59642A (en)
NZ (1) NZ193133A (en)
PH (1) PH19336A (en)
PT (1) PT70932A (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457756A (en) * 1982-04-14 1984-07-03 Kern Eugene B Nose bleed clip
US5913872A (en) * 1997-10-10 1999-06-22 Newcore, Usa Magnetic nose clip
ES2292206T3 (en) * 1997-10-10 2008-03-01 Bioniche Life Sciences Inc. ADMINISTRATION SYSTEM OF PHARMACOS.
US5989270A (en) * 1998-04-15 1999-11-23 Eunsung Development Co., Ltd. Nose shape adjusting instrument
NL1011884C2 (en) * 1999-04-23 2000-10-24 Maasland Nv Nose ring.
GB2363575A (en) * 2000-04-13 2002-01-02 Nicola Herron A Nose Clip
US6701924B1 (en) * 2002-10-07 2004-03-09 Richard D. Land, Jr. Nasal filter
US7156099B1 (en) * 2004-08-03 2007-01-02 Jenkins Cloytillia M Nostril filtering system
US20080015484A1 (en) * 2006-07-14 2008-01-17 Wolfensberger Joan A Apparatus and method for cleaning and disinfecting body piercings
US20110230907A1 (en) * 2010-03-19 2011-09-22 Sinocclusive Llc Arterial tamponade device and method
US20110230829A1 (en) * 2010-03-19 2011-09-22 Fitzgerald Patrick J Arterial Tamponade Device and Method
US8673219B2 (en) 2010-11-10 2014-03-18 Invention Science Fund I Nasal passage insertion device for treatment of ruminant exhalations
WO2013163635A1 (en) * 2012-04-27 2013-10-31 Med-Dev Corporation Devices and methods of controlling the propagation of mrsa, staph and other infections that colonize in the nose
JP6554270B2 (en) * 2014-07-09 2019-07-31 ユニバーシティ・オブ・タンペレUniversity of Tampere Biological stimulation apparatus and biological stimulation method
BR102017026941B1 (en) * 2017-12-14 2023-10-17 Wta- Watanabe Tecnologia Aplicada Eirele - Epp SELF-ADAPTABLE NASAL FIXATION DEVICE FOR ANIMALS
EP4066631A1 (en) * 2021-04-01 2022-10-05 Ceva Santé Animale Nose ring for ruminants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB816887A (en) * 1957-02-15 1959-07-22 Reginald Arthur Laxton Improvements in or relating to nose clips
CH49187A (en) * 1910-03-17 1911-01-16 Jakob Kuster respirator
NL20293C (en) * 1921-09-11
US2015617A (en) * 1932-09-08 1935-09-24 Ferdinand C Claudius Clip
US2064986A (en) * 1936-02-06 1936-12-22 Mezz David Nose clip
DD95648A5 (en) * 1971-05-22 1973-02-12

Also Published As

Publication number Publication date
DK113280A (en) 1980-09-18
IE800526L (en) 1980-09-17
DE3065495D1 (en) 1983-12-15
IL59642A (en) 1983-10-31
AU5652380A (en) 1980-09-25
EG15007A (en) 1985-12-31
CA1136499A (en) 1982-11-30
EP0016431A1 (en) 1980-10-01
FI800782A (en) 1980-09-18
IL59642A0 (en) 1980-06-30
HU178841B (en) 1982-07-28
AR223515A1 (en) 1981-08-31
ES489393A1 (en) 1980-09-16
US4369783A (en) 1983-01-25
PT70932A (en) 1980-04-01
PH19336A (en) 1986-03-21
AU538641B2 (en) 1984-08-23
NZ193133A (en) 1983-09-02
IE49189B1 (en) 1985-08-21

Similar Documents

Publication Publication Date Title
EP0016431B1 (en) Nose clip for the prophylactic or therapeutic treatment of cattle
DE2742896C2 (en) Orthodontic support for straightening teeth
DE10085045B3 (en) Applicator for reflex therapy
DE2913509A1 (en) TOOTH REGULATION ELEMENT
EP0938874A2 (en) Orthodontic bracket
DE69931354T2 (en) DEVICE FOR ADMINISTERING A MEDICAMENT
DE7720821U1 (en) CONNECTING AND / OR ANCHORING PART WITH A STONE SURFACE FOR BONE PROSTHESES, IN PARTICULAR JOINT PROSTHESES
DE2728690C3 (en) Joint implant
CH632149A5 (en) CARRIER ELEMENT FOR PROSTHESIS PROVIDED IN PARTICULAR FOR THE FORMATION OF AN ARTIFICIAL JOINT.
DE69309689T2 (en) METHOD AND DEVICE FOR APPLYING A MEDICINE CAPSULE TO A CARRIER
EP0161295B1 (en) Device for binding parts of dental prosthesis by adhesion
DE2825232C2 (en)
DE3242415A1 (en) TOOTH PEN AND TORQUE WRENCH FOR SAME, AND METHOD FOR FILLING A TOOTH ROOT BY SAME
EP0157909A1 (en) Corpuscules containing medicaments
DE69838223T2 (en) ARRANGEMENT FOR MEDICATION INTRODUCTION
CH624829A5 (en) Method and device for shoeing a horse
AT518996B1 (en) Animal ear tag
DE2910629A1 (en) Nose clip for medicating cattle - has receiving surfaces for medicinal bodies mutually inclined and twisted
EP1773713B1 (en) Horse snaffle bit and method for the production thereof
DE3751103T2 (en) Device for external fixation of bones with biocompression.
DE7929781U1 (en) NOSE CLASP FOR PROPHYLACTIC OR THERAPEUTIC TREATMENT OF CATTLE
DE102022133031B3 (en) Assemblable toy figure
EP0988835A2 (en) Device for promoting growth of upper and/or lower jaw
DE9300471U1 (en) Joint prosthesis
DE2926283A1 (en) Nose clip for cattle treatment - has bow holder for plug fitments with reservoir sleeves or pads, with bows angled together at ends for firm fitting

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT NL SE

17P Request for examination filed

Effective date: 19810207

ITF It: translation for a ep patent filed

Owner name: ING. C. GREGORJ S.P.A.

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB IT NL SE

REF Corresponds to:

Ref document number: 5229

Country of ref document: AT

Date of ref document: 19831115

Kind code of ref document: T

REF Corresponds to:

Ref document number: 3065495

Country of ref document: DE

Date of ref document: 19831215

ET Fr: translation filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 19840217

Year of fee payment: 5

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19840222

Year of fee payment: 5

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19840331

Year of fee payment: 5

Ref country code: BE

Payment date: 19840331

Year of fee payment: 5

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19840413

Year of fee payment: 5

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 19860306

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19860331

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Effective date: 19870314

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19870315

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Effective date: 19870331

BERE Be: lapsed

Owner name: HOECHST A.G.

Effective date: 19870331

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19871001

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee
GBPC Gb: european patent ceased through non-payment of renewal fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19871130

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Effective date: 19871201

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19881118

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Effective date: 19890331

EUG Se: european patent has lapsed

Ref document number: 80101337.6

Effective date: 19880215